Free Trial

Citi’s Results Say This About The Stock Market

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)

Citibank stock outlook

Key Points

  • Citi's first quarter 2024 results may give investors the insight they need to ride the market in the coming months.
  • Despite uncertain Fed timing, the bank is betting on consumers and a new rally higher in the stock market. 
  • Fundamentally, clients and corporations are sure that 2024 will see lower interest rates and better business.
  • 5 stocks we like better than CME Group

Traders who postpone the potential interest rate cuts from the Federal Reserve (the Fed) could be in for a reckoning. According to the FedWatch tool at CME Group Inc., the Fed started the year proposing cuts as soon as March 2024; traders now see these cuts pushed back as far as September 2024.

After reporting its first quarter 2024 results, Citigroup Inc. NYSE: C kicked off the financial stocks earnings season on a better-than-expected note. That stock is up about two points in the pre-market hours of Friday morning. Despite contracting financials, underlying trends at the bank suggest potentially brighter times ahead for the stock market.

On a corporate and consumer level, retail investors can gain enough insight from Citi’s figures to adjust their portfolios accordingly. Before the party starts, here’s an overview of what has driven the stock market to its recent all-time highs and why these levels may not be at as much risk as some think.

Squeezing The Last Leg

The way Citi made its money during the quarter can give investors insight into what is happening underneath the hood of financial markets. Investment banking revenues were reported to be 35% higher over the past 12 months.

When investment banking activity gets hotter, the Financial Select Sector SPDR Fund NYSEARCA: XLF tends to do well, which is why it has kept in lockstep with the broader S&P 500 in making new all-time highs.

Mergers and acquisitions (M&A) typically bring the bulk of fees for investment banks, and these departments only churn when their clients can make deals happen. Low interest rates, or the expectation of lower rates, enable cheaper financing for these deals.

Despite traders betting on postponed Fed rate cuts, Wall Street's pulse is still on a surprise this year. Citi's net interest income has declined by 2% every quarter, signaling the start of a credit market adjustment to the coming rate cuts this year.

Inside the banking segment, debt capital markets (DCM) fees were up 62% during the year. In contrast, equity capital markets (ECM) fees pushed only 57%. Because rates remained elevated during 2023, it makes sense to see DCM banking activity this high; however, that may soon change.

Citi said in its investor presentation, “Seeing good momentum in announced Technology and Healthcare M&A.” This is corporate lingo for “get ready,” as these two sectors are set to push markets higher in the coming months.

With the Health Care Select Sector SPDR Fund NYSEARCA: XLV at all-time highs, it makes sense that M&A activity could start in healthcare stocks. Lower interest rates will likely create jobs for the sector and spur consumer discretionary activity and corporate IT spending to help technology stocks.

Consumers Need Help

Despite elevated interest rates, consumer loans rose by 1% quarterly and 5% over the past year. The problem lies in the number of clients who now have to rely on credit cards to fight off stubbornly high inflation rates affecting the U.S. economy.

As a percentage of total FICO scores, those below 660 now make up 15% of total loans, up from 14% a year prior. Those above 660 saw a similar 1% decline, meaning the credit profile of these credit cards is deteriorating.

Non-performing loans, characterized as those with 90 days or more of delinquency (nonpayments), are also on the rise. Valued at only $1 billion in the first quarter of 2023, they are now $1.8 billion and making up 4.5% of average loans, where they only represented 2.8% a year ago.

Citi may be taking the long view on this one, knowing that U.S. consumer sentiment is now at a 3-year high; the bank could be betting on lower rates ahead by taking some short-term risk in lower-profile consumer loans.

Stocks Are Still in Fashion

Trading revenues helped Citi beat analyst expectations despite a low volatility index (VIX). Revenue compositions between stocks and fixed-income (bonds) also have much to say about this trend.

Equity markets revenue was up 5% over the year, while fixed-income markets revenue declined by 10%. Retail investors can jump to all conclusions here, but one root truth remains: Citi likes stocks over bonds, and so do its traders.

Citi outperformed peers like Bank of America Inc. NYSE: BAC over the past six months; an 11% gap over its competitor can be a sign of more to come from the sector and an even better signal for the stock market’s next run higher.

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)

Should you invest $1,000 in CME Group right now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Citigroup (C)
4.7789 of 5 stars
$63.58+0.9%3.33%18.81Moderate Buy$63.66
Bank of America (BAC)
4.5233 of 5 stars
$39.70+1.4%2.42%13.74Moderate Buy$38.70
Health Care Select Sector SPDR Fund (XLV)N/A$144.42-0.3%1.38%23.82N/AN/A
Financial Select Sector SPDR Fund (XLF)N/A$41.61+0.6%1.68%18.32N/AN/A
CME Group (CME)
4.7897 of 5 stars
Compare These Stocks  Add These Stocks to My Watchlist 

Gabriel Osorio-Mazilli

About Gabriel Osorio-Mazilli


Contributing Author

Value Stocks, Asian Markets, Macro Economics


Gabriel Osorio-Mazilli has been a contributing writer for MarketBeat since 2023.

Areas of Expertise

Value investing, long/short trading, options, emerging markets


CFA Level I candidate; Goldman Sachs corporate training; independent courses

Past Experience

Analyst at Goldman Sachs, associate at Citigroup, senior financial analyst in real estate

Featured Articles and Offers

Search Headlines: